Search Ontology:
ChEBI
celastrol
- Term ID
- CHEBI:63959
- Synonyms
-
- (2R,4aS,6aS,12bR,14aS,14bR)-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-2-picenecarboxylic acid
- (2R,4aS,6aS,12bR,14aS,14bR)-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydropicene-2-carboxylic acid
- 3-hydroxy-9beta,13alpha-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid
- D:A-Friedo-24-noroleana-1(10),3,5,7-tetraen-29-oic acid, 3-hydroxy-2-oxo-, (20alpha)-
- Tripterine
- Definition
- A pentacyclic triterpenoid that is 24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid bearing an oxo substituent at position 2, a hydroxy substituent at position 3 and two methyl groups at positions 9 and 13. An antioxidant and anti-inflammatory agent. Potently inhibits lipid peroxidation in mitochondria and inhibits TNF-α-induced NFκB activation. Also shown to inhibit topoisomerase II activity in vitro (IC50 = 7.41 μM).
- References
-
- cas:34157-83-0
- hmdb:HMDB0002385
- patent:KR20100097843
- patent:US2011263693
- pubmed:11809076
- pubmed:15593077
- pubmed:20934245
- pubmed:20954803
- pubmed:21134410
- pubmed:21414301
- pubmed:21425580
- pubmed:21466843
- pubmed:21569548
- pubmed:21666907
- pubmed:21850367
- pubmed:21865725
- pubmed:21866552
- pubmed:22087583
- pubmed:22206928
- pubmed:22334592
- reaxys:2194425
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from celastrol
Phenotype where environments contain celastrol
Phenotype modified by environments containing celastrol
Phenotype affecting celastrol
Human Disease Model